Natural Course and Therapeutic Effect of Recurrent Acute Pancreatitis
Condition(s) studied
Investigational drug(s) / intervention(s)
endoscopic intervention, surgery or conservative treatment: Personal information and treatment of the enrolled subjects will be collected.
Study summary
The goal of this observational cohort study is to learn about the etiology, natural course, therapeutic effect and outcome of recurrent acute pancreatitis patients. The main question it aims to answer is:
Does endoscopic intervention, surgery or conservative treatment reduce the recurrence of acute pancreatitis? What are the risk factors affecting the recurrence of acute pancreatitis?
Patients will be closely followed and clinical information will be recorded.
Eligibility
Primary outcome measure(s)
- Recurrence rate of acute pancreatitis — Through study completion, an average of 1 year
Acute pancreatitis is diagnosed according to the revised Atlanta classification, which requires 2 of the 3 following criteria: (1) abdominal pain suggestive of pancreatitis, (2) serum amylase and/or lipase greater than 3 times the upper limit of normal, (3) and crosssectional imaging (CT or MRI) findings consistent with acute pancreatitis.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Changhai Hospital | Shanghai | Shanghai Municipality | Recruiting |
More Changhai Hospital trials in China
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06355206 on ClinicalTrials.gov ↗ ← All trials in China